GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | November 28, 2024 |
PDB ID | UniProt ID ▲ | Title | Descriptor |
---|---|---|---|
7YG5 | Q15878 | Structure of human R-type voltage-gated CaV2.3-alpha2/delta1-beta1 channel complex in the topiramate-bound state | |
8EPL | Q15878 | Human R-type voltage-gated calcium channel Cav2.3 at 3.1 Angstrom resolution | |
8EPM | Q15878 | Human R-type voltage-gated calcium channel Cav2.3 CH2II-deleted mutant at 3.1 Angstrom resolution | |
7XLQ | Q15878 | Structure of human R-type voltage-gated CaV2.3-alpha2/delta1-beta1 channel complex in the ligand-free (apo) state | |
6WM3 | Q15904 | Human V-ATPase in state 2 with SidK and ADP | V-type proton ATPase 116 kDa subunit a isoform 1, V-type proton ATPase subunit C 1, V-type proton ATPase subunit E 1, V-type proton ATPase subunit G 1, V-type proton ATPase subunit e 1, Ribonuclease kappa (E.C.3.1.-.-), V-type proton ATPase subunit H, V-type proton ATPase subunit S1, Renin receptor, V-type proton ATPase 21 kDa proteolipid subunit, V-type proton ATPase 16 kDa proteolipid subunit, V-type proton ATPase subunit d 1, V-type proton ATPase catalytic subunit A (E.C.7.1.2.2), V-type proton ATPase subunit B, brain isoform, V-type proton ATPase subunit D, V-type proton ATPase subunit F |
6WLW | Q15904 | The Vo region of human V-ATPase in state 1 (focused refinement) | V-type proton ATPase 116 kDa subunit a isoform 1, V-type proton ATPase subunit S1, Renin receptor, V-type proton ATPase 21 kDa proteolipid subunit, V-type proton ATPase 16 kDa proteolipid subunit, V-type proton ATPase subunit d 1, V-type proton ATPase subunit e 1, Ribonuclease kappa (E.C.3.1.-.-) |
7U4T | Q15904 | Human V-ATPase in state 2 with SidK and mEAK-7 | |
6WM2 | Q15904 | Human V-ATPase in state 1 with SidK and ADP | V-type proton ATPase 116 kDa subunit a isoform 1, V-type proton ATPase subunit C 1, V-type proton ATPase subunit E 1, V-type proton ATPase subunit G 1, V-type proton ATPase subunit e 1, Ribonuclease kappa (E.C.3.1.-.-), V-type proton ATPase subunit H, V-type proton ATPase catalytic subunit A (E.C.7.1.2.2), V-type proton ATPase subunit B, brain isoform, k, V-type proton ATPase subunit D, V-type proton ATPase subunit F, V-type proton ATPase subunit S1, Renin receptor, V-type proton ATPase 21 kDa proteolipid subunit, V-type proton ATPase 16 kDa proteolipid subunit, V-type proton ATPase subunit d 1 |
6WM4 | Q15904 | Human V-ATPase in state 3 with SidK and ADP | V-type proton ATPase catalytic subunit A (E.C.7.1.2.2), V-type proton ATPase subunit B, brain isoform, SidK, V-type proton ATPase 116 kDa subunit a isoform 1, V-type proton ATPase subunit C 1, V-type proton ATPase subunit E 1, V-type proton ATPase subunit G 1, V-type proton ATPase subunit D, V-type proton ATPase subunit F, V-type proton ATPase subunit S1, Renin receptor, V-type proton ATPase 21 kDa proteolipid subunit, V-type proton ATPase 16 kDa proteolipid subunit, V-type proton ATPase subunit d 1, V-type proton ATPase subunit e 1, Ribonuclease kappa (E.C.3.1.-.-), V-type proton ATPase subunit H |
7UNF | Q15904 | CryoEM structure of a mEAK7 bound human V-ATPase complex | |
3T7D | Q15JG1 | Vall from streptomyces hygroscopicus in complex with trehalose | Putative glycosyltransferase |
4F9F | Q15JG1 | Crystal Structure of VldE, the pseudo-glycosyltransferase, in complex with GDP and Trehalose | |
2IHZ | Q15KI8 | Crystal structure of multifunctional sialyltransferase from pasteurella multocida with CMP-3F-Neu5Ac and alpha-lactose bound | |
2ILV | Q15KI8 | crystal structure of multifunctional sialyltransferase from Pasteurella multocida with CMP and alpha-lactose bound | |
4OVQ | Q160Z9 | CRYSTAL STRUCTURE OF A TRAP PERIPLASMIC SOLUTE BINDING PROTEIN FROM ROSEOBACTER DENITRIFICANS, TARGET EFI-510230, WITH BOUND BETA-D-GLUCURONATE | |
8EUC | Q16281 | Cryo-EM structure of cGMP bound human CNGA3/CNGB3 channel in GDN, transition state 2 | |
8EV8 | Q16281 | Cryo-EM structure of cGMP bound truncated human CNGA3/CNGB3 channel in lipid nanodisc, closed state | |
8EV9 | Q16281 | Cryo-EM structure of cGMP bound truncated human CNGA3/CNGB3 channel in lipid nanodisc, transition state 1 | |
8EVA | Q16281 | Cryo-EM structure of cGMP bound truncated human CNGA3/CNGB3 channel in lipid nanodisc, transition state 2 | |
8EVB | Q16281 | Cryo-EM structure of cGMP bound truncated human CNGA3/CNGB3 channel in lipid nanodisc, pre-open state | |
8EVC | Q16281 | Cryo-EM structure of cGMP bound truncated human CNGA3/CNGB3 channel in lipid nanodisc, open state | |
8ETP | Q16281 | Cryo-EM structure of cGMP bound closed state of human CNGA3/CNGB3 channel in GDN | |
8EU3 | Q16281 | Cryo-EM structure of cGMP bound human CNGA3/CNGB3 channel in GDN, transition state 1 | |
7RHS | Q16281 | Cryo-EM structure of apo-state of human CNGA3/CNGB3 channel | |
7ZAY | Q16394 | Human heparan sulfate polymerase complex EXT1-EXT2 | |
7SCH | Q16394 | Cryo-EM structure of the human Exostosin-1 and Exostosin-2 heterodimer | |
7SCJ | Q16394 | Cryo-EM structure of the human Exostosin-1 and Exostosin-2 heterodimer in complex with a 4-sugar oligosaccharide acceptor analog | |
7SCK | Q16394 | Cryo-EM structure of the human Exostosin-1 and Exostosin-2 heterodimer in complex with a 7-sugar oligosaccharide acceptor analog | |
7UQX | Q16394 | Cryo-EM structure of the human Exostosin-1 and Exostosin-2 heterodimer in complex with UDP-GlcNAc | |
7UQY | Q16394 | Cryo-EM structure of the human Exostosin-1 and Exostosin-2 heterodimer in complex with UDP-GlcA | |
5TCO | Q16539 | Human p38 MAP Kinase in Complex with Dibenzosuberone Compound 1 | |
6HWU | Q16539 | Crystal structure of p38alpha in complex with a photoswitchable 2-Azothiazol-based Inhibitor (compound 2) | |
6HWT | Q16539 | Crystal structure of p38alpha in complex with a reduced photoswitchable 2-Azothiazol-based Inhibitor (compound 31) | |
6QYX | Q16539 | p38(alpha) MAP kinase with the activation loop of ERK2 | |
6HWV | Q16539 | Crystal structure of p38alpha in complex with a photoswitchable 2-Azoimidazol-based Inhibitor (compound 3) | |
1ZYJ | Q16539 | Human P38 MAP Kinase in Complex with Inhibitor 1a | |
1ZZ2 | Q16539 | Two Classes of p38alpha MAP Kinase Inhibitors Having a Common Diphenylether Core but Exhibiting Divergent Binding Modes | |
2FSL | Q16539 | mitogen activated protein kinase p38alpha (D176A+F327S) activating mutant form-A | |
2FSM | Q16539 | mitogen activated protein kinase p38alpha (D176A+F327S) activating mutant form-B | |
2FSO | Q16539 | mitogen activated protein kinase p38alpha (D176A) activating mutant | |
2FST | Q16539 | mitogen activated protein kinase p38alpha (D176A+F327L) activating mutant | |
2NPQ | Q16539 | A Novel Lipid Binding Site in the p38 alpha MAP Kinase | |
3GCP | Q16539 | Human P38 MAP Kinase in Complex with SB203580 | |
3GCQ | Q16539 | Human P38 MAP kinase in complex with RL45 | |
3GCS | Q16539 | Human P38 MAP kinase in complex with Sorafenib | |
3GCU | Q16539 | Human P38 MAP kinase in complex with RL48 | |
3GCV | Q16539 | Human P38 MAP Kinase in Complex with RL62 | |
3HEC | Q16539 | P38 in complex with Imatinib | |
3HUB | Q16539 | Human p38 MAP Kinase in Complex with Scios-469 | |
3HUC | Q16539 | Human p38 MAP Kinase in Complex with RL40 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024